Book a demo
Research & KnowledgeEvent: September 6, 2026

Eugia US LLC published a study finding that 30 percent of study participants had lung cancer cells shrink.

Published

Signal category

Research & Knowledge

Quote

30 percent of study participants had lung cancer cells shrink

Donald DeWitt|Eugia US LLC team

Company

Eugia US LLC

Experience the Eugia Difference

Industry
Pharmaceutical Manufacturing
Location
Hightstown, US
Company size
51 employees

Eugia is an independent specialty pharmaceutical company focused on delivering generic sterile injectables, oncology, hormones, and ophthalmic medicines. Our best-in-class, dedicated manufacturing and R&D capabilities are poised to meet today’s customer needs, and we are committed to providing our customers and partners with high-quality specialty medicines. Our name embodies who we aspire to be as a company – EU meaning “good” and hyGIA being the goddess of good health – together reflecting our focus on delivering products that are foundational to ensuring good health for millions of people around the world. For more information, visit EugiaUS.com

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.